How do we obtain clear hydrogen for the chemical industry?

April 9, 2020

Methane pyrolysis enables hydrogen and carbon to be produced from methane in a CO2-free process. BASF develops this method as clean hydrogen is a key element of future chemical production.

Spotlight

Kymab Ltd

Kymab is discovering and developing fully human monoclonal antibody therapeutics using our pioneering Kymouse™ platform. We are building a rich pipeline of assets in four therapeutic spaces: immuno-oncology, inflammation, haematology and infectious diseases. The Kymouse strains have more base-pairs of the human immunoglobulin genes than any other model. Their performance is exceptional: virtually every mouse responds to challenge, producing high-titre polyclonal antibodies to a variety of antigens including highly conserved human antigens. We are improving the value of Kymouse platform still further for therapeutic antibody and vaccine discovery through novel developments.

OTHER VIDEOS

A new era of temperature measurement in the chemical industry

video | March 19, 2020

ABB's non-invasive temperature sensor increases safety and provides greater flexibility while maintaining your measurement quality....

Watch Now

DECK 7 - General Data Protection Regulations (GDPR)

video | May 23, 2018

DECK 7 is committed to protecting our customers' data and safeguarding their privacy....

Watch Now

Innovations in Steel and Petrochemical Production for a Sustainable Future - Dassault Systèmes

video | March 11, 2020

Innovations in Steel and Petrochemical Production for a Sustainable Future - Dassault Systèmes. Thomas Grand, Dassault Systèmes' Vice President, Energy and Materials, shares his insights on how Dassault Systèmes' solutions have enabled significant improvements in steel production scheduling efficiency, as well as development of faster acting catalysts in petrochemical production. These innovations in steel and petrochemcial production can lead to huge reductions in global CO2 emissions....

Watch Now

AGRI Challenge: Non-chemical weed management in arable cropping systems

video | March 10, 2020

Agriculture in the EU and worldwide has become increasingly dependent on the use of pesticides. Change is needed because the use of these chemicals can impact the environment and the health of animals and humans....

Watch Now

Spotlight

Kymab Ltd

Kymab is discovering and developing fully human monoclonal antibody therapeutics using our pioneering Kymouse™ platform. We are building a rich pipeline of assets in four therapeutic spaces: immuno-oncology, inflammation, haematology and infectious diseases. The Kymouse strains have more base-pairs of the human immunoglobulin genes than any other model. Their performance is exceptional: virtually every mouse responds to challenge, producing high-titre polyclonal antibodies to a variety of antigens including highly conserved human antigens. We are improving the value of Kymouse platform still further for therapeutic antibody and vaccine discovery through novel developments.

Events